Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.020
-0.060 (-5.56%)
At close: Mar 27, 2026, 4:00 PM EDT
1.030
+0.010 (0.98%)
After-hours: Mar 27, 2026, 7:19 PM EDT

Vivani Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
9.438.93107.072.32
Research & Development
18.1315.7516.9714.1711
Total Operating Expenses
27.5624.6826.9721.2413.32
Operating Income
-27.56-24.68-26.97-21.24-13.32
Other Non-Operating Income (Expense)
0.951.191.317.350.55
Total Non-Operating Income (Expense)
0.951.191.317.350.55
Pretax Income
-26.61-23.49-25.65-13.89-12.77
Net Income
-26.61-23.49-25.65-13.89-12.77
Net Income to Common
-26.61-23.49-25.65-13.89-12.77
Shares Outstanding (Basic)
6255513833
Shares Outstanding (Diluted)
6255513833
Shares Change (YoY)
13.47%8.12%32.98%15.56%382.51%
EPS (Basic)
-0.43-0.43-0.50-0.36-0.39
EPS (Diluted)
-0.43-0.43-0.50-0.36-0.39
Free Cash Flow
-25.49-21.34-24.59-19.13-11.52
Free Cash Flow Per Share
-0.41-0.39-0.48-0.50-0.35
EBITDA
-27.13-24.28-26.61-20.86-12.98
EBIT
-27.56-24.68-26.97-21.24-13.32
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q